Cross-Cultural Validation of the RECAP of Atopic Eczema Question-naire in a Swedish Population.

Autor: Sigurdardottir G; Department of Dermatology and Venereology in Östergötland, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. gunnthorunn.sigurdardottir@liu.se., Alsterholm M; Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Division of Dermatology and Venereology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Andersson CD; Department of Dermatology and Venereology in Östergötland, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden., Bradley M; Division of Dermatology and Venereology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Dermatology, Karolinska University Hospital, Stockholm, Sweden., Sandström Falk M; Vasakliniken Dermatology Clinic, Gothenburg, Sweden., Johansson EK; Division of Dermatology and Venereology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Dermatology, Karolinska University Hospital, Stockholm, Sweden., Lundqvist M; Dermatology, Karolinska University Hospital, Stockholm, Sweden., Sonesson A; Department of Dermatology and Venereology, Skåne University Hospital, Lund, Sweden; Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, Sweden., Svensson Å; Department of Dermatology and Venereology, Skåne University Hospital, Lund, Sweden; Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden., Theodosiou G; Department of Dermatology and Venereology, Skåne University Hospital, Malmö, Sweden., Vrang S; Patients' organisation Atopikerna, The Swedish Asthma and Allergy Association, Stockholm, Sweden., Von Kobyletzki LB; Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Jazyk: angličtina
Zdroj: Acta dermato-venereologica [Acta Derm Venereol] 2024 Jun 19; Vol. 104, pp. adv38889. Date of Electronic Publication: 2024 Jun 19.
DOI: 10.2340/actadv.v104.38889
Abstrakt: A Swedish translation of the patient-reported outcome measure for assessing long-term control of atopic dermatitis, Recap of atopic eczema (RECAP), has not been validated. Cross-cultural translation and multi-centre validation of the translated RECAP questionnaire were therefore performed. Disease severity was assessed using the validated Investigator Global Assessment Scale for atopic dermatitis (vIGA-ADTM). The Swedish RECAP was completed by 208 individuals aged 16 years or older with a median age of 36 years (interquartile range [IQR] 27-48). The participants considered the questionnaire suitable for assessing eczema control. The median RECAP score (range 0-28) was 12 (IQR 5-19). The mean and median vIGA-ADTM scores (range 0-4) were 2 (standard deviation [SD] 2) and 3 (IQR 2-4), respectively. A correlation between RECAP and the vIGA-ADTM was observed (p < 0.001). There was no significant change in scores for participants who answered the questionnaire twice within 14 days. Over time, improved or worsened eczema, as evaluat-ed by vIGA-ADTM, affected RECAP scores significantly (p < 0.001). The study suggests that RECAP can assess AD control in a Swedish clinical setting and shows -acceptable reliability.
Databáze: MEDLINE